Last Updated: 10 Nov 2024
Executive Summary
Cardinal Health Inc. (CAH) is a leading healthcare services company with a market capitalization of $29.18 billion. The company has a strong financial position with an EBITDA of $2.92 billion and EPS of $5.3. CAH has a dividend yield of 0.0171% and a trailing PE ratio of 22.75. The company's shares are currently trading at $120.56, within the 52-week range of $92.74 and $121.79.
Company Overview
Cardinal Health is a global healthcare services company that provides a wide range of products and services to healthcare providers, manufacturers, and consumers. The company's products and services include pharmaceuticals, medical supplies, laboratory equipment, and healthcare information technology. Cardinal Health has a global presence with operations in more than 50 countries.
Fundamental Analysis
Cardinal Health's financial performance has been strong in recent years. The company's revenue has grown at a CAGR of 4.5% over the past five years. The company's net income has also grown at a CAGR of 6.5% over the past five years. Cardinal Health's balance sheet is strong with a debt-to-equity ratio of 0.45. The company's cash flow from operations is also strong, with a CAGR of 7.5% over the past five years.
Technical Analysis
Cardinal Health's stock price has been trending higher in recent months. The stock price is currently above its 50-day and 200-day moving averages. The stock price is also above its Ichimoku cloud, which is a bullish indicator.
Short Term Outlook
Cardinal Health's stock price is expected to continue to trend higher in the short term. The company's strong financial performance and positive technical indicators suggest that the stock is a good buy.
Long Term Outlook
Cardinal Health's long-term outlook is also positive. The company is well-positioned to benefit from the growing demand for healthcare services. The company's strong financial position and global presence should allow it to continue to grow in the long term.
Analyst Recommendations
The majority of analysts have a buy rating on Cardinal Health. The average analyst target price is $125.02.
